- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Board Meeting, 05-08-2026: Outcome of Board Meeting
05-08-2026 | 04:51 pm
05-08-2026 | 04:51 pm
Biocon's board has approved Q1 financial results. Consolidated revenue hit ₹4,336 Cr, with net profit at ₹136.8 Cr. The company proposed a ₹0.50/share dividend. Biocon Biologics is now a wholly-owned subsidiary via a share swap.
No comments yet. Be the first to comment!